Immunovant, Inc. (IMVT)

Healthcare · Biotechnology · NASDAQ

Immunovant, Inc. (IMVT) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $8.25B and a free-cash-flow yield of -6.2%.

Market cap	$8.25B
Trailing P/E	—
FCF yield	-6.2%
Revenue growth (YoY)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live IMVT data on Nama Insights →